Ipilimumab and Nivolumab Combined with Anthracycline-Based Chemotherapy in Metastatic Hormone Receptor-Positive Breast Cancer: a Randomized Phase 2b Trial
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2024)
Key words
Immune Checkpoint Inhibitors,Breast Neoplasms,T-Lymphocytes, Regulatory,Nivolumab,Ipilimumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined